CXCR3 and melanoma: Indeed, CCL5 and CXCL9 co-expression synergistically led to CD8+ T-cell infiltration in a murine melanoma model.55 Unfortunately, the CXCR3-signalling ligands are often downregulated with disease progression in melanoma.